Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults

Phase 1

Completed

Conditions: Influenza
Virus Diseases

Interventions: Biological: Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca)

First Posted Date: 2009-03-02

Last Posted Date: 2013-01-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 20

Registration Number: NCT00853255

Locations: 🇺🇸
University of Rochester Vaccine Evaluation Isolation Unit, St. Mary's Hospital, Rochester, New York, United States

Intensive Viral Dynamics Substudy of A5248

Completed

Conditions: Treatment Naive
HIV Infections

First Posted Date: 2009-02-27

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 11

Registration Number: NCT00852618

Locations: 🇺🇸
University of Colorado Hospital CRS, Aurora, Colorado, United States
🇺🇸
IHV Baltimore Treatment CRS, Baltimore, Maryland, United States
🇺🇸
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS, Boston, Massachusetts, United States

and more 3 locations

Screening Protocol for Genetic Diseases of Allergic Inflammation

Completed

Conditions: HaTS
Eosinophilic Disease
Immune Deficiency
Elevated IgE Level
Urticaria Anaphylaxis

First Posted Date: 2009-02-27

Last Posted Date: 2025-06-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 824

Registration Number: NCT00852943

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy

Phase 2

Completed

Conditions: Herpes Zoster
HIV Infections

Interventions: Biological: ZOSTAVAX
Biological: Placebo

First Posted Date: 2009-02-26

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 395

Registration Number: NCT00851786

Locations: 🇺🇸
The Ponce de Leon Center CRS, Atlanta, Georgia, United States
🇺🇸
The Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸
Thomas Jefferson Univ. Med. Ctr. CRS, Philadelphia, Pennsylvania, United States

and more 40 locations

Safety of Acidform Lubricant in HIV-Uninfected Women

Phase 1

Completed

Conditions: HIV Infections

Interventions: Drug: Acidform Lubricant
Drug: HEC gel

First Posted Date: 2009-02-25

Last Posted Date: 2013-12-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 35

Registration Number: NCT00850837

Locations: 🇺🇸
Albert Einstein College of Medicine - East Campus GCRC (Herold) Non-Network CRS, Bronx, New York, United States

Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

Phase 1

Terminated

Conditions: Idiopathic CD4+ T-Lymphocytopenia

Interventions: Drug: CYT107

First Posted Date: 2009-02-09

Last Posted Date: 2015-10-15

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 21

Registration Number: NCT00839436

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

Phase 4

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Etanercept
Drug: Adalimumab

First Posted Date: 2009-02-05

Last Posted Date: 2021-09-22

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 63

Registration Number: NCT00837434

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 4 locations

Longitudinal Study of the Human Intestinal Microbiome

Phase 1

Completed

Conditions: Dysbacteriosis

Interventions: Drug: Ciprofloxacin

First Posted Date: 2009-01-30

Last Posted Date: 2021-07-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00832286

Locations: 🇺🇸
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults

Phase 1

Completed

Conditions: Dengue Fever

Interventions: Biological: rDEN3delta30/31-7164

First Posted Date: 2009-01-28

Last Posted Date: 2013-11-15

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 56

Registration Number: NCT00831012

Locations: 🇺🇸
Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

Phase 1

Completed

Conditions: Asthma
Rhinitis, Allergic, Perennial

Interventions: Biological: Glycerinated German Cockroach Allergenic Extract
Biological: Placebo

First Posted Date: 2009-01-27

Last Posted Date: 2017-03-21

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 54

Registration Number: NCT00829985

Locations: 🇺🇸
National Jewish Center, Denver, Colorado, United States
🇺🇸
Childrens Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Boston University School of Medicine, Boston, Massachusetts, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy